Neogen Corporation

NASDAQ:NEOG

Medical - Diagnostics & Research

Healthcare
$11.08 +1.79%

+$0.16 today

Market cap
$2.42B
Beta
1.80
P/E (TTM)
-3.3
EPS (TTM)
-$2.80
52W Low $4.56High $11.43

Volume 1.79M

Average 2.53M

NEOG Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Neogen CorporationNASDAQ: NEOG

Gross Margin · Q1 FY2027 · quarter ended Aug 2026

Gross margin widens to 47.4%

Gross margin was 47.4% in Q1 FY2027, up 2.0 pp from a year earlier. On a trailing-twelve-month basis it was 47.4%, up 6.3 pp year over year. Over 3 fiscal years it narrowed by 2.4 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2026 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterAug 2026
47.4%-0.5 pp QoQ
Last fiscal yearMay 2026
46.9%-0.2 pp YoY
LTMAug 2026
47.4%+6.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+2.0 pp——
1 year-0.2 pp——
3 years-2.4 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2026
46.9%
Year-over-year change
-0.2pp

Gross Margin vs competitors

How NEOG compares with its peers on the latest reported figures

  • NEOG's LTM Aug 2026 gross margin of 47.4% is the 5th highest of the 7 companies compared; the peer median is 58.1%.
  • Its year-over-year change of +6.3 pp is the 2nd highest of 7, against a peer median of +0.8 pp.
  • Over three fiscal years its change of -2.4 pp compares with a peer median of +1.8 pp.
NEOG Competitors Peer median
Gross Margin for NEOG and competitors
Company Period LTM level YoY 3-year change
MRKMerck & Co., Inc.LTM Jun 202675.4% -0.1 pp+1.3 pp
ZTSZoetis Inc.LTM Jun 202670.9% +0.8 pp+2.7 pp
IDXXIDEXX Laboratories, Inc.LTM Sep 202662.7% +1.0 pp+2.3 pp
ELANElanco Animal Health IncorporatedLTM Sep 202653.5% +7.1 pp-1.2 pp
NEOGNeogen CorporationLTM Aug 202647.4% +6.3 pp-2.4 pp
BCPCBalchem CorporationLTM Sep 202636.5% +0.6 pp+6.0 pp
PAHCPhibro Animal Health CorporationLTM Mar 202632.5% +0.8 pp+0.6 pp
Peer median (excluding NEOG) 58.1%+0.8 pp+1.8 pp

Competitors are the stored peer set for NEOG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
FY2026
May 2026
Revenue527.16M822.45M924.22M894.66M870.4M
Cost of Revenue284.15M416.49M461.59M473.29M461.9M
Gross Profit243.01M405.96M462.64M421.38M408.5M
Gross Margin46.1%49.4%50.1%47.1%46.9%
Research & Development17.05M26.04M22.48M21.09M18.4M
Selling, General & Admin167.35M342.4M382.76M401.97M411.7M
Operating Expenses184.4M368.44M385.21M411.96M430.1M
Depreciation & Amortization24.13M90.47M121.23M125.67M116.3M
EBITDA84.34M124.39M182.6M(937.75M)164.9M
EBITDA Margin16.0%15.1%19.8%-104.8%18.9%
Operating Income58.62M37.52M77.43M9.42M(21.6M)
Operating Margin11.1%4.6%8.4%1.1%-2.5%
Interest Income1.34M3.17M6.36M3.11M0
Interest Expense72K55.96M73.39M71.62M57.6M
Other Income / Expenses1.59M(59.56M)(91.73M)(1.14B)12.6M
Income Before Tax60.21M(22.04M)(14.31M)(1.13B)(9M)
Pre-Tax Margin11.4%-2.7%-1.5%-126.7%-1.0%
Income Tax Expense11.9M828K(4.88M)(41.07M)(1.1M)
Net Income48.31M(22.87M)(9.42M)(1.09B)(7.9M)
Net Margin9.2%-2.8%-1.0%-122.1%-0.9%
EPS (Basic)0.45(0.12)(0.04)(5.03)(0.04)
EPS (Diluted)0.45(0.12)(0.04)(5.03)(0.04)
Weighted Avg Shares107.68M188.88M216.48M216.89M217.5M
Weighted Avg Shares (Diluted)108.02M188.88M216.48M216.89M217.5M

Neogen Corporation

NASDAQ:NEOG

Intrinsic Alpha fair value

Locked

Current Price

$11.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.